Carcinoma, Non-Small-Cell Lung  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00923949: Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

Terminated
2
1
US
Pioglitazone
National Cancer Institute (NCI)
Non-Small-Cell Lung Cancer
03/10
03/10
NCT01342770: Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Terminated
2
6
US
Laboratory Biomarker Analysis, Pioglitazone Hydrochloride, Actos, Pioglitazone.HCl, Quality-of-Life Assessment, Quality of Life Assessment
National Cancer Institute (NCI)
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma, Stage IIB Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer
12/12
02/13

Download Options